Relapsed/Refractory (R/R) Epstein-Barr virus (EBV) - Pipeline Insight, 2020

  • RnM3882150
  • |
  • 14 February, 2020
  • |
  • 106 Pages
  • |
  • DelveInsight
  • |
  • Pharmaceuticals
1-user PDF :    $1,500.00
Site PDF :    $3,000.00
Enterprise PDF :    $4,500.00

Make an enquiry before buying this Report



Purchase this Report

$1,500.00
$3,000.00
$4,500.00
1,215.50
2,431.00
3,646.49
1,379.47
2,758.93
4,138.40
163,296.00
326,592.00
489,888.00
113,518.35
227,036.70
340,555.05
Credit card Logo